Cytotoxic versus genotoxic effects of nitric oxide (NO)

Toxicology Letters

Volumn 106, Issue 1, 1999, Pages 59-67

  Stopper, H ^a   Moller M ^a   Bommel H M ^b   Schmidt, H H H W ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

3 Morpholino sydnonimine hydrochloride; Comet assay; Micronuclei; NO, nitric oxide; NONOate, spermine NONOate; NOS, NO synthetases; ONOO , peroxynitrite; SIN 1, 3 morpholino sydnonimine hydrochloride; Spermine NONOate

Indexed keywords

LINSIDOMINE; NITRIC OXIDE; PEROXYNITRITE; SPERMIDINE DERIVATIVE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENOTOXICITY; IN VITRO STUDY; LEUKEMIA L 5178 Y; MICRONUCLEUS TEST; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL DIVISION; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICRONUCLEUS TESTS; MOLSIDOMINE; MUTAGENS; NITRIC OXIDE; TUMOR CELLS, CULTURED;

EID: 0344435244     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00019-3     Document Type: Article

References (34)

1. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
2. Anderson D., Yu T.-W., Phillips B.J., Schmezer P. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the comet assay. Mutat. Res. 307:1994;261-271.
3. Barrett J.C. Cellular and molecular mechanisms of asbestos carcinogenicity: implications for biopersistence. Environ. Health Persp. 102(Suppl. 5):1994;19-23.
4. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
5. Delaney C.A., Green M.H.L., Lowe J.E., Green I.C. Endogeneous nitric oxide induced by interleukin-1b in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the comet assay. FEBS Lett. 333:1993;291-295.
6. Donovan P.J., Smith G.T., Lawlor T.E., Cifone M.A., Murli H., Keefer L.K. Quantification of diazeniumdiolate mutagenicity in four different in vitro assays. Nitric Oxide. 1:1997;158-166.
7. Eizirik D.L., Delaney C.A., Green M.H.L., Cunningham J.M., Thorpe J.R., Pipeleers D.G., Hellerström C., Green I.C. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol. Cell. Endocrinol. 118:1996;71-83.
8. Fairbairn D.W., Olive P.L., O'Neill K.L. The comet assay: a comprehensive review. Mutat. Res. 339:1995;37-59.
9. Farias-Eisner R., Sherman M.P., Aeberhard E., Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;9407-9411.
10. Feelisch M., Stamler J.S. Donors of nitrogen oxides. Feelisch W., Stamler J.S. Methods in Nitric Oxide Research. 1996;71-118 Wiley and Sons, Chichester.
11. Feelisch M., Ostrowski J., Noack E. On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol. 14(Suppl. 11):1989;S13-S22.
12. Felley-Bosco E., Mirkovitch J., Ambs S. et al. Nitric oxide and ethylnitrosourea: relative mutagenicity in the p53 tumor suppressor and hypoxanthine-phosphoribosyltransferase genes. Carcinogenisis. 16:1995;2069-2074.
13. Förstermann U., Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedebergs Arch. Pharmacol. 352:1995;351-364.
14. Gordon L.L., Weitzman S.A. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood. 76:1990;655-663.
15. Green M.H.L., Lowe J.E., Delaney C.A., Green I.C. Comet assay to detect nitric oxide-dependent DNA damage in mammalian cells. Methods Enzymol. 269:1996;243-266.
16. Hartmann A., Speit G. Genotoxic effects of chemicals in the single cell gel test with human blood cells in relation to the induction of sister-chromatid exchanges. Mutat. Res. 346:1995;49-56.
17. Hartmann A., Speit G. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol. Lett. 90:1997;183-188.
18. Henderson L., Wolfreys A., Fedyk J., Bourner C., Windebank S. The ability of the comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis. 13:1998;89-94.
19. Liu R.H., Hotchkiss J.H. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res. 339:1995;73-89.
20. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.-W., Sokol K., Hutchinson N., Chen H., Mudgett J.S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
21. Matsuoka A., Yamazaki N., Suzuki T., Hayashi M., Sofuni T. Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res. 272:1993;223-236.
22. Miller B., Albertini S., Locher F., Thybaud V., Lorge E. Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: industrial experience. Mutat. Res. 392:1997;45-60.
23. Miller B., Potter-Locher F., Seelbach A., Stopper H., Utesch D., Madle S. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group on the in vitro micronucleus test. Mutat. Res. 410:1998;81-116.
24. Nathan C.F., Hibbs Jr. J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:1991;65-70.
25. Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Nat. Acad. Sci. USA. 89:1992;3030-3034.
26. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305:1994;253-264.
27. Schmidt H.H.H.W., Hofmann H., Schindler U., Shutenko Z.S., Cunningham D.D., Feelisch M. No NO. from NO synthase. Proc. Nat. Acad. Sci. USA. 93:1996;14492-14497.
28. Stopper H., Müller S.O. Micronuclei as a biological endpoint for genotoxicity: a minireview. Toxicol. Vitro. 11:1997;661-667.
29. Tamir S., Tannenbaum S.R. The role of nitric oxide in the carcinogenic process. Biochim. Biophys. Acta. 1288:1996;F31-F36.
30. Tamir S., DeRojas-Walker T., Wishnok J.S., Tannenbaum S.R. DNA damage and genotoxicity by nitric oxide. Methods Enzymol. 269:1996;230-243.
31. Vamvakas S., Schmidt H.H.H.W. Just say NO to cancer? J Natl Cancer Inst. 89:1997;406-407.
32. Vock E.H., Lutz W.K., Hormes P., Hoffmann H.D., Vamvakas S. Discrimination between genotoxicity and cytoxicity in the induction of DNA double strand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide, Triton X-100, and γ-irradiation. Mutat. Res. 413:1998;83-94.
33. Wei X.-Q., Charles I.G., Smith A., Ure J., Feng G.-J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune response in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
34. Wiseman H., Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313:1996;17-29.